Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
Key Trends | Description |
Rising Prevalence of Pericarditis | Pericarditis is increasingly prevalent, leading to a significant number of hospitalizations annually in the United States. Surge in cardiovascular issues, owing to fast paced, and sedentary lifestyles among individuals is a notable market trend. |
Emergence of Novel Therapies | Innovative therapies are being developed and tested in clinical trials for the treatment of pericarditis. The introduction of novel treatment options is anticipated to meet the growing demand for effective management of the condition. |
Increased Research and Development Investments | Key players in the healthcare industry are investing significantly in research and development activities aimed at advancing the understanding and treatment of pericarditis. |
Heightened Awareness of Heart Health Among Patients | Growing awareness of heart health and cardiovascular diseases among patients is leading to early detection and diagnosis of pericarditis. This increased awareness supports the demand for pericarditis treatments. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 2.44 billion in 2023 driven by the rising prevalence of pericarditis across the 8 major markets.
The market is anticipated to grow at a CAGR of 5.24% during the forecast period of 2024-2032, likely to reach a market value of USD 3.87 billion by 2032.
The rise in cardiovascular diseases and growing awareness surrounding heart health are fuelling the demand for the market.
One of the significant trends in the market is the surge in drug approvals from health regulatory agencies such as the FDA. In February 2024, the United States FDA granted Orphan Drug Designation (ODD) to Cardiol Therapeutics' CardiolRx™, a small molecule drug candidate developed to treat pericarditis.
Based on the diagnostic methods, the market is segmented into electrocardiogram (ECG), echocardiogram, computerized tomography (CT), and X-ray.
Based on the drug type, the market is segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, and others.
Major end users of the market include hospitals and clinics, as well as medical institutes and research laboratories.
Major distribution channels of the market include hospital pharmacies, retail pharmacies, online pharmacies, and others.
The major regions of the market include the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India.
Key players involved in the market are Kiniksa Pharmaceuticals, Pfizer Inc., Bayer AG, AstraZeneca Plc, Sanofi, Johnson and Johnson Services, Inc., Merck & Co., Inc., Allergan Plc., Novartis AG, and Perkin Elmer Inc.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124